📢Do you want to discover how to deliver next generation single-cell functional analysis and provide actionable insights that are streamlining cell therapy discovery and development? Join our Webinar with Richard Harbottle, Head of DNA Vector Research at DKFZ German Cancer Research Center, and Massimo Bocchi, founder of Cellply. 📅 11 July 🕑 08:00 PST | 11:00 EST | 17:00 CEST Don’t miss this oppotunity! Sign up here ➡️ https://lnkd.in/djJrr-Vq #Webinar #CellTherapy #TCR
Cellply’s Post
More Relevant Posts
-
See #XeniumXplorers in action! Check out this article detailing how National Cancer Center Research Institute researchers are analyzing surgical tumor samples from the institute’s extensive biobank with #singlecellspatial. We can’t wait to see the results! #genexindia #genexindiabioscience
-
-
🚨CALL FOR PAPERS🚨 The #CallforPapers is open for our new #SpecialIssue - "The role of physiological therapies in the management of cancer". This Special Issue will focus on the research and application of physiological therapies in cancer management! 🔗https://buff.ly/3QzZARF
-
-
If you’re attending #ASHI in San Antonio, you won’t want to miss Versiti’s own Matthew Anderson, MD, PhD, as he moderates a discussion on cellular therapies in cancer on Oct. 16! This session will focus on the latest innovations in CAR-T and NK cell therapies and opportunities for advancements with these treatments. https://bit.ly/46Lh4zt
-
-
We're here with another episode of #ChatGJP! With the American Association for Cancer Research #AACR annual meeting coming up next week, we asked our CSO Dr. Gary Patti "What breakthroughs has metabolomics contributed to in the field of cancer research?" Visit booth 3349 in San Diego to learn more about how our #metabolomics, #proteomics, and #multiomics solutions can provide breakthroughs in your research!
-
☑️ Strong partnerships with academia and the life sciences industry. ☑️ Scientific and clinical intelligence powered by ORIEN and Total Cancer Care - the world's largest and longest running observational research study in #oncology. ☑️ Best-in-class, deepest multimodal dataset for discovery research. Learn more about how we are changing the way cancer is studied, treated, and prevented: https://ow.ly/NURW50QsETJ #CancerResearch #PrecisionMedicine
-
-
Online now in GIE’s Articles in Press: “Magnifying image-enhanced endoscopy-only mode boosted early cancer diagnostic efficiency: a multicenter randomized controlled trial” by Ai-Rui Jiang et al. Find it at https://lnkd.in/grztAgPi.
-
-
Poster 2 of 3 Hemant Rathi would be presenting our research titled: “Real-World Effectiveness and Safety of First-Line Pembrolizumab Monotherapy for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis” at #ISPORAnnual Co- authors: Geetank Kamboj, Aastha Radotra, PARINITA BARMAN, Shirish Dongare, PhD, Surabhi Aggarwal, Hemant Rathi #ISPOR2024 #HEOR #SkywardAnalytics #LiteratureReviews #SLR #MetaAnalysis
-
-
Author and Research Operations Manager at the Brain Tumour Research Center in Toronto.
On #thisDayInScience in 1988, the Oncomouse was patented, a monumental step in cancer research. Engineered with genes predisposing it to tumours, this mouse has vastly advanced our understanding of cancer. #oncomouse #CancerResearch Read this post and more on my Typeshare Social Blog: https://lnkd.in/dhfvxt7U
-
-
🚨CALL FOR PAPERS🚨 The #CallforPapers is open for our new #SpecialIssue - "The role of physiological therapies in the management of cancer". This Special Issue will focus on the research and application of physiological therapies in cancer management! 🔗https://buff.ly/3QzZARF
-
